Urinary Vitamin C Loss in Diabetic Subjects
Urinary Vitamin C Loss in Subjects With and Without Diabetes
2 other identifiers
observational
5,000
1 country
1
Brief Summary
Several studies have reported that diabetic subjects have lower plasma vitamin C concentrations than non-diabetic subjects. Although urinary vitamin C loss in diabetic subjects was reported to be increased in two studies, these are difficult to interpret due to lack of controlled vitamin C intake, inadequate sampling, lack of control subjects, or methodology uncertainties in vitamin C assay and sample processing. Consequently, it is unclear whether diabetic subjects truly have both low plasma and high urine vitamin C concentrations. We propose that low plasma vitamin C concentrations in diabetic subjects are due in part to inappropriate renal loss of vitamin C in these subjects but not in healthy controls. We will study nondiabetic controls and cohorts with diabetes. Vitamin C concentrations in plasma, RBCs, and urine will be measured in outpatients. In those willing to be admitted to the Clinical Center, we will measure vitamin C pharmacokinetics to determine the relative bioavailability for vitamin C in individuals with and without abnormal urinary loss of vitamin C (or renal leak). Single nucleotide polymorphisms (SNPs) will be determined in genomic DNA responsible for the two proteins mediating sodium dependent vitamin C transport, SVCT1 and SVCT2. We will also explore mechanisms underlying abnormal urinary vitamin C loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2003
CompletedFirst Posted
Study publicly available on registry
October 28, 2003
CompletedStudy Start
First participant enrolled
April 11, 2006
CompletedMay 5, 2026
April 28, 2026
October 27, 2003
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma, neutrophil and RBC Vitamin C concentrates
Measurements of plasma, neutrophil and red blood cell vitamin c concentrations in diabetic subjects as compared to healthy controls.
end of study
Secondary Outcomes (2)
Urinary vitamin C concentration
end of study
Determine the renal threshold and relative bioavailability for vitamin C
end of study
Study Arms (3)
Diabetes Type I
Subjects with Type I diabetes mellitus
Diabetes Type II
Subjects with Type II diabetes mellitus
Healthy Volunteers
Healthy Volunteers
Eligibility Criteria
Community sample.
You may qualify if:
- To be included in the study, study subjects should be:
- Aged 18-65 years.
- Either:
- Have no diagnosis of diabetes: "nondiabetic controls", or
- Have a diagnosis in their medical history of either Type 1 or Type 2 diabetes
You may not qualify if:
- Unable or unwilling to provide a signed and dated informed consent form
- Unable or unwilling to comply with study procedures and lifestyle considerations
- Study participants interested in participating in Arms 2 and/or 3 will be excluded from this further participation if they meet any of the following:
- significant organ malfunction leading to clinical instability including liver disease, pulmonary disease, ischemic heart disease, heart failure, stroke, peripheral vascular disease, and anemia at investigator discretion
- other serious or chronic illness; history of serious or chronic illness; coronary artery disease, or peripheral vascular disease resulting in clinical instability
- pregnancy or lactation
- presence of other conditions which, in the judgment of the investigators, can influence vitamin C metabolism or vitamin C renal handling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (4)
Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med. 1986 Apr 3;314(14):892-902. doi: 10.1056/NEJM198604033141407. No abstract available.
PMID: 3513016BACKGROUNDGoodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983 Jun 3;249(21):2917-21.
PMID: 6842805BACKGROUNDFata FT, Herzlich BC, Schiffman G, Ast AL. Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann Intern Med. 1996 Feb 1;124(3):299-304. doi: 10.7326/0003-4819-124-3-199602010-00003.
PMID: 8554224BACKGROUNDEbenuwa I, Violet PC, Tu H, Lee C, Munyan N, Wang Y, Niyyati M, Patra K, Wilkins KJ, Parrow N, Levine M. Altered RBC deformability in diabetes: clinical characteristics and RBC pathophysiology. Cardiovasc Diabetol. 2024 Oct 18;23(1):370. doi: 10.1186/s12933-024-02453-2.
PMID: 39425096DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ifechukwude C Ebenuwa, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2003
First Posted
October 28, 2003
Study Start
April 11, 2006
Last Updated
May 5, 2026
Record last verified: 2026-04-28